Compare IQV & OTIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQV | OTIS |
|---|---|---|
| Founded | 1982 | 1853 |
| Country | United States | United States |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Consumer Electronics/Appliances |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.3B | 34.9B |
| IPO Year | 2013 | 2019 |
| Metric | IQV | OTIS |
|---|---|---|
| Price | $166.19 | $92.65 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 8 |
| Target Price | ★ $233.33 | $104.13 |
| AVG Volume (30 Days) | 2.6M | ★ 4.1M |
| Earning Date | 05-08-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.81% |
| EPS Growth | ★ 4.67 | N/A |
| EPS | ★ 7.84 | 3.50 |
| Revenue | ★ $9,739,000,000.00 | N/A |
| Revenue This Year | $6.77 | $7.37 |
| Revenue Next Year | $5.91 | $4.89 |
| P/E Ratio | ★ $21.59 | $26.60 |
| Revenue Growth | ★ 41.60 | N/A |
| 52 Week Low | $134.65 | $84.00 |
| 52 Week High | $247.05 | $106.83 |
| Indicator | IQV | OTIS |
|---|---|---|
| Relative Strength Index (RSI) | 26.66 | 62.97 |
| Support Level | $161.94 | $90.55 |
| Resistance Level | $171.14 | $92.91 |
| Average True Range (ATR) | 10.96 | 2.03 |
| MACD | -2.88 | 0.48 |
| Stochastic Oscillator | 15.47 | 99.89 |
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Otis is the largest global elevator and escalator supplier by revenue with around 18% global market share. In 1854 Otis' founder and namesake Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed. The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15- to 20-year useful life of an elevator. As the largest global OEM, Otis has amassed an installed base under service that exceeds 2 million elevators. Its business model is similar to that of its closest competitors Kone, Schindler, and TK Elevator.